Verity Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-553
Closed -$215K 230
2025
Q2
$215K Hold
553
0.1% 187
2025
Q1
$241K Sell
553
-185
-25% -$74.3K 0.1% 167
2024
Q4
$204K Sell
738
-1,024
-58% -$429K 0.11% 177
2024
Q3
$841K Buy
1,762
+260
+17% +$139K 0.32% 84
2024
Q2
$814K Buy
1,502
+651
+76% +$344K 0.32% 78
2024
Q1
$441K Hold
851
0.25% 105
2023
Q4
$401K Hold
851
0.26% 106
2023
Q3
$371K Sell
851
-1
-0.1% -$454 0.27% 97
2023
Q2
$379K Sell
852
-74
-8% -$34.1K 0.28% 96
2023
Q1
$426K Buy
926
+14
+2% +$6.66K 0.25% 102
2022
Q4
$468K Buy
912
+171
+23% +$86.8K 0.4% 83
2022
Q3
$337K Buy
+741
New +$355K 0.35% 98
2022
Q1
$632K Buy
1,276
+70
+6% +$32K 0.4% 79
2021
Q4
$559K Buy
1,206
+520
+76% +$219K 0.33% 92
2021
Q3
$256K Sell
686
-451
-40% -$171K 0.17% 152
2021
Q2
$434K Buy
1,137
+201
+21% +$76.8K 0.24% 116
2021
Q1
$336K Buy
+936
New +$301K 0.2% 135

Other funds holding ELV

Verity Asset Management's ELV Position: Q3 2025 in Review

Verity Asset Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 553 shares — an estimated $215K sold.

Verity Asset Management first reported a position in ELV in Q1 2021 and held it in 17 quarters. The position peaked at $841K in Q3 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Verity Asset Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Verity Asset Management sold 553 Elevance Health shares in Q3 2025, an estimated $215K.
  • Verity Asset Management first reported a position in Elevance Health in Q1 2021 and held it in 17 quarters.
  • Verity Asset Management's Elevance Health position peaked at $841K in Q3 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Verity Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.